Hasenkamp J - Search Results

1

Retroperitoneal fibrosis as manifestation of chronic GVHD after allogeneic hematopoietic SCT.

Dicke C, Kertész A, Henke RP, Hasenkamp J, Jung W, Trümper L, Wulf GG. Dicke C, et al. Among authors: hasenkamp j. Bone Marrow Transplant. 2013 Mar;48(3):467-8. doi: 10.1038/bmt.2012.165. Epub 2012 Sep 10. Bone Marrow Transplant. 2013. PMID: 22964591 No abstract available.

2

Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells: the need for T cells early after transplantation to induce a graft-versus-lymphoma effect.

Glass B, Nickelsen M, Dreger P, Claviez A, Hasenkamp J, Wulf G, Trümper L, Schmitz N. Glass B, et al. Among authors: hasenkamp j. Bone Marrow Transplant. 2004 Sep;34(5):391-7. doi: 10.1038/sj.bmt.1704600. Bone Marrow Transplant. 2004. PMID: 15273707 Clinical Trial.

3

Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma.

Wulf GG, Hasenkamp J, Jung W, Chapuy B, Truemper L, Glass B. Wulf GG, et al. Among authors: hasenkamp j. Bone Marrow Transplant. 2005 Aug;36(3):271-3. doi: 10.1038/sj.bmt.1705036. Bone Marrow Transplant. 2005. PMID: 15937499 No abstract available.

4

Resistance against natural killer cell cytotoxicity: analysis of mechanisms.

Hasenkamp J, Borgerding A, Wulf G, Uhrberg M, Jung W, Dingeldein S, Truemper L, Glass B. Hasenkamp J, et al. Scand J Immunol. 2006 Oct;64(4):444-9. doi: 10.1111/j.1365-3083.2006.01803.x. Scand J Immunol. 2006. PMID: 16970688 Free article.

5

Self-tolerance of human natural killer cells lacking self-HLA-specific inhibitory receptors.

Hasenkamp J, Borgerding A, Uhrberg M, Falk C, Chapuy B, Wulf G, Jung W, Trümper L, Glass B. Hasenkamp J, et al. Scand J Immunol. 2008 Mar;67(3):218-29. doi: 10.1111/j.1365-3083.2007.02058.x. Epub 2008 Jan 22. Scand J Immunol. 2008. PMID: 18226015 Free article.

6

Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma.

Borgerding A, Hasenkamp J, Glass B, Wulf G, Trümper L. Borgerding A, et al. Among authors: hasenkamp j. Ann Hematol. 2010 Mar;89(3):283-9. doi: 10.1007/s00277-009-0820-9. Epub 2009 Sep 2. Ann Hematol. 2010. PMID: 19727725 Free PMC article.

7

Progression of a CD4+/CD56+ blastic plasmacytoid DC neoplasm after initiation of extracorporeal photopheresis in an allogeneic transplant recipient.

Dohm A, Hasenkamp J, Bertsch HP, Maas JH, Truemper L, Wulf G. Dohm A, et al. Among authors: hasenkamp j. Bone Marrow Transplant. 2011 Jun;46(6):899-900. doi: 10.1038/bmt.2010.196. Epub 2010 Aug 23. Bone Marrow Transplant. 2011. PMID: 20729923 No abstract available.

8

Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescue.

Hohloch K, Sahlmann CO, Lakhani VJ, Wulf G, Glass B, Hasenkamp J, Meller J, Riggert J, Trümper L, Griesinger F. Hohloch K, et al. Among authors: hasenkamp j. Ann Hematol. 2011 Nov;90(11):1307-15. doi: 10.1007/s00277-011-1199-y. Epub 2011 Mar 1. Ann Hematol. 2011. PMID: 21360108 Clinical Trial.

9

Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial.

Glass B, Hasenkamp J, Wulf G, Dreger P, Pfreundschuh M, Gramatzki M, Silling G, Wilhelm C, Zeis M, Görlitz A, Pfeiffer S, Hilgers R, Truemper L, Schmitz N; German High-Grade Lymphoma Study Group. Glass B, et al. Among authors: hasenkamp j. Lancet Oncol. 2014 Jun;15(7):757-66. doi: 10.1016/S1470-2045(14)70161-5. Epub 2014 May 11. Lancet Oncol. 2014. PMID: 24827808 Clinical Trial.

10

Loss of donor chimerism in remission after allogeneic stem cell transplantation of T-prolymphocytic leukemia patients following alemtuzumab induction therapy.

Szuszies CJ, Hasenkamp J, Jung W, Koch R, Trümper L, Wulf GG. Szuszies CJ, et al. Among authors: hasenkamp j. Int J Hematol. 2014 Nov;100(5):425-8. doi: 10.1007/s12185-014-1678-8. Epub 2014 Sep 26. Int J Hematol. 2014. PMID: 25258193

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters